Knight Therapeutics
Specialty pharmaceutical company focused on acquiring or in-licensing.
Launch date
Employees
Market cap
€405m
Enterprise valuation
€339m (Public information from Sep 2024)
Share price
CAD6.13 GUD.TO
Westmount Quebec (HQ)
Authorizing premium user...